The Blue Cross and Blue Shield plan that Indianapolis-based WellPoint Inc. operates in Connecticut has backed out of managing
part of an insurance program rather than disclose the rates it pays doctors and its approach to denying prescription drug
payments. Did WellPoint make the right call? How deep should government dig into a companyâ??s internal operations?
Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.